mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.02 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.02 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.03 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.03 |